Stockscreener 앱 받기
107.54
0.22%
0.24
시간 외 거래:
107.54
Zimmer Biomet Holdings Inc 주식(ZBH)의 최신 뉴스
Zimmer Biomet Holdings Inc. Inches Above Key Support — Safe to HoldJuly 2025 Action & AI Driven Price Forecasts - beatles.ru
Do Wall Street Analysts Like Zimmer Biomet Stock? - Barchart.com
Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock - Yahoo Finance
North America Pectus Bar Market Forecast Report to 2031, - GlobeNewswire
North America Pectus Bar Market Forecast Report to 2031, with Leading Player Profiles for KLS Martin Group, Biotech, Zimmer Biomet Holdings, Ventura Medical Technologies, and MedXpert - Yahoo Finance
Should I hold or sell Zimmer Biomet Holdings Inc. nowJuly 2025 Selloffs & Accurate Entry and Exit Point Alerts - newsyoung.net
Monogram Technologies Announces Merger with Zimmer Biomet - MSN
Stock Analysis | Zimmer Biomet OutlookA Divergent Picture Between Strong Fundamentals and Weak Technicals - AInvest
Monogram Technologies Inc. SEC 10-Q Report - TradingView
Is Zimmer Biomet Holdings Inc. still a buy after recent gainsPortfolio Profit Report & Daily Technical Stock Forecast Reports - thegnnews.com
Zimmer Biomet Holdings: Unusual Items Mask Strong Profit Growth - AInvest
Published on: 2025-08-14 17:26:03 - beatles.ru
Zimmer Biomet’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Zimmer Biomet’s Strong Q2 Performance and Optimistic Outlook - The Globe and Mail
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q2 2025 Earnings Call Transcript - MSN
Zimmer Biomet Expects Strong Q2 Earnings, Raises Guidance on Robust Performance and Strategic Acquisitions - AInvest
Orthopedic Devices Company Evaluation Report 2024-2025 | Stryker, Zimmer Biomet, and Johnson & Johnson MedTech Lead Across Joint Replacement, Trauma, and Surgical Solutions - Yahoo Finance
Is Zimmer Biomet Holdings Inc. stock forming a cup and handleHigh Conviction Technical Setups - classian.co.kr
Needham Maintains a Neutral Stance on Zimmer Biomet Holdings (ZBH) - MSN
Zimmer (ZBH) Builds Robotics Growth Pipeline, but BofA Sees Limited Near-Term Upside - MSN
Zimmer Biomet (ZBH) Jumps After Raising 2025 Outlook on Strong Hip and Knee Sales—Is Momentum Sustainable? - simplywall.st
Zimmer Biomet Acquires Monogram Technologies, Boosting Robotics Growth Pipeline, but BofA Sees Limited Near-Term Upside - AInvest
Healthcare Sector Analysts Weigh In on Sangamo Biosciences, Pliant Therapeutics, and Zimmer Biomet Holdings - AInvest
What You Need To Know Ahead of Zimmer Biomet's Earnings Release - MSN
ZBH Stock Gains On Q2 Earnings and Revenue Beat, '25 EPS View Up - MSN
A Quick Look at Today's Ratings for Zimmer Biomet Holdings(ZBH.US), With a Forecast Between $96 to $138 - 富途牛牛
While shareholders of Zimmer Biomet Holdings (NYSE:ZBH) are in the red over the last five years, underlying earnings have actually grown - simplywall.st
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MSN
Zimmer Biomet Holdings Maintains Hold Rating Amid Volatility Concerns - AInvest
Zimmer Biomet Surges Despite 404th-Ranked Liquidity as Earnings Outperform and UBS Maintains Sell Rating - AInvest
UBS Raises Price Target for Zimmer Biomet Holdings (ZBH) to $96 | ZBH Stock News - GuruFocus
RBC Capital Raises Zimmer Biomet PT to $115, Maintains Outperform Rating - AInvest
UBS maintains Sell rating, raises Zimmer Biomet PT to $96 from $91. - AInvest
Morgan Stanley Raises Price Target on Zimmer Biomet to $100 From $95 - MarketScreener
Raymond James maintains Outperform rating on Zimmer Biomet with new PT of $113. - AInvest
Zimmer Biomet Holdings, Inc. shares fall 1.09% intraday as brokerages adjust price targets and global growth concerns persist. - AInvest
RBC Raises Price Target on Zimmer Biomet Holdings to $115 From $112, Keeps Outperform Rating - MarketScreener
Zimmer Biomet price target raised to $113 from $104 at Raymond James - TipRanks
UBS Hikes Price Target on Zimmer Biomet to $96 From $91, Maintains Sell Rating - MarketScreener
Bernstein raises Zimmer Biomet stock price target to $105 on improving outlook - Investing.com Canada
A Quick Look at Today's Ratings for Zimmer Biomet Holdings(ZBH.US), With a Forecast Between $95 to $138 - 富途牛牛
Zimmer Biomet Boosts 2025 Outlook on Strong Portfolio Growth and Reduced Tariff Impacts - AInvest
Zimmer Biomet price target raised to $96 from $91 at UBS - TipRanks
Zimmer Biomet raises 2025 outlook amid strong portfolio growth - Yahoo Finance
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - Yahoo Finance
Zimmer Biomet Holdings: Balancing Strong Segment Growth with US Knee Challenges – Hold Rating Maintained - TipRanks
Zimmer Biomet Q2 2025 net sales up 7% to USD 2.077B - Medical Buyer
Jefferies Adjusts Price Target on Zimmer Biomet to $110 From $103, Maintains Hold Rating - MarketScreener
Bernstein Adjusts Price Target on Zimmer Biomet to $105 From $100, Maintains Market Perform Rating - MarketScreener
JPMorgan Adjusts Price Target on Zimmer Biomet to $115 From $105, Maintains Overweight Rating - MarketScreener
Spinal Fusion Devices Market Outlook Report 2025-2029: Revenues to Grow by $2.9 Billion Driven by Rising Spinal Disorders, Technological Advances, and Increasing Device Launches - GlobeNewswire Inc.
Zimmer: Q2 Earnings Snapshot - Connecticut Post
Zimmer Biomet Reports Strong Q2 2025 Results - TipRanks
Zimmer Biomet Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Zimmer Biomet Surges 7.99% on Revised Earnings and Tariff Relief Ranks 287th in $420M Volume - AInvest
Zimmer Biomet Reports Q2 Earnings, Raises Full-Year Outlook - InkFreeNews.com
0.86%
0.67%
자본화:
|
볼륨(24시간):